Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZS92
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,358
Award facts
- Contract value 100% obligated
- $16,357.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,357.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Xiaflex 0.9 mg vials, with an ultimate completion date of October 17, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Xiaflex is a prescription injectable medication primarily used in the treatment of Dupuytren's contracture, a condition affecting hand connective tissue. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established position to deliver specialized pharmaceutical products directly to Department of Defense healthcare sites. The company's robust portfolio of federal contract awards demonstrates consistent capability in supplying branded and generic prescription drugs, biologics, and medical consumables across various therapeutic categories to military and federal healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FZS92?
SPE2DB25FZS92 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZS92 worth?
The government has obligated $16,358 on SPE2DB25FZS92.
Is contract SPE2DB25FZS92 an order under another contract?
Yes. SPE2DB25FZS92 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS92 competed?
The extent of competition for SPE2DB25FZS92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award